Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Int J Mol Sci ; 23(1)2021 Dec 25.
Artículo en Inglés | MEDLINE | ID: mdl-35008638

RESUMEN

Rigosertib is multi-kinase inhibitor that could represent an interesting therapeutic option for non-resectable patients with cholangiocarcinoma, a very aggressive hepatic cancer with limited effective treatments. The Western blotting technique was used to evaluate alterations in the expression of proteins involved in the regulation of the cell cycle of cholangiocarcinoma EGI-1 cells. Our results show an increase in EMI1 and Cyclin B protein levels after Rigosertib treatment. Moreover, the phosphorylation of CDK1 is significantly reduced by Rigosertib, while PLK1 expression increased after 24 h of treatment and decreased after 48 h. Finally, we evaluated the role of p53. Its levels increase after Rig treatment, and, as shown in the cell viability experiment with the p53 inhibitor Pifithrin, its activity is necessary for the effects of Rigosertib against the cell viability of EGI-1 cells. In conclusion, we hypothesized the mechanism of the action of Rigosertib against cholangiocarcinoma EGI-1 cells, highlighting the importance of proteins involved in the regulation of cell cycles. The CDK1-Cyclin B complex and p53 play an important role, explaining the Block in the G2/M phase of the cell cycle and the effect on cell viability.


Asunto(s)
División Celular/efectos de los fármacos , Colangiocarcinoma/tratamiento farmacológico , Fase G2/efectos de los fármacos , Glicina/análogos & derivados , Sulfonas/farmacología , Proteína Quinasa CDC2/metabolismo , Proteínas de Ciclo Celular/metabolismo , Colangiocarcinoma/metabolismo , Ciclina B/metabolismo , Glicina/farmacología , Humanos , Fosforilación/efectos de los fármacos , Inhibidores de Proteínas Quinasas/farmacología , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Transducción de Señal/efectos de los fármacos , Células Tumorales Cultivadas , Proteína p53 Supresora de Tumor/metabolismo , Quinasa Tipo Polo 1
2.
Brain ; 142(10): 3158-3175, 2019 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-31365052

RESUMEN

Huntington's disease is a neurodegenerative disorder caused by a CAG repeat expansion in exon 1 of the huntingtin gene. Striatal projection neurons are mainly affected, leading to motor symptoms, but molecular mechanisms involved in their vulnerability are not fully characterized. Here, we show that eIF4E binding protein (4E-BP), a protein that inhibits translation, is inactivated in Huntington's disease striatum by increased phosphorylation. Accordingly, we detected aberrant de novo protein synthesis. Proteomic characterization indicates that translation specifically affects sets of proteins as we observed upregulation of ribosomal and oxidative phosphorylation proteins and downregulation of proteins related to neuronal structure and function. Interestingly, treatment with the translation inhibitor 4EGI-1 prevented R6/1 mice motor deficits, although corticostriatal long-term depression was not markedly changed in behaving animals. At the molecular level, injection of 4EGI-1 normalized protein synthesis and ribosomal content in R6/1 mouse striatum. In conclusion, our results indicate that dysregulation of protein synthesis is involved in mutant huntingtin-induced striatal neuron dysfunction.


Asunto(s)
Factor 4E Eucariótico de Iniciación/fisiología , Enfermedad de Huntington/genética , Biosíntesis de Proteínas/fisiología , Animales , Conducta Animal , Cuerpo Estriado/metabolismo , Modelos Animales de Enfermedad , Factor 4E Eucariótico de Iniciación/genética , Humanos , Proteína Huntingtina/genética , Proteína Huntingtina/metabolismo , Enfermedad de Huntington/metabolismo , Interneuronas/metabolismo , Masculino , Ratones , Ratones Transgénicos , Neostriado/patología , Degeneración Nerviosa/patología , Neuronas/metabolismo , Proteínas Nucleares/genética , Fosforilación , Proteómica
3.
J Food Sci Technol ; 57(8): 2941-2948, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32624599

RESUMEN

Native buckwheat starch was extracted and modified by heat-moisture treatment (HMT) with different treatment time (15, 30 and 45 min) to investigate its effect on physicochemical, morphological, functional properties, starch profile (rapidly digestible starch, RDS; slowly digestible starch, SDS and resistant starch, RS fractions) and expected glycemic index (eGI). Results revealed that with increasing time duration of HMT from 15 to 45 min, amylose content, pasting temperature and thermostability increased substantially whereas swelling power, solubility and viscosity parameters decreased. The SEM micrographs showed that HMT caused fissures in the granule and surface indentation. HMT-45 (starch treated for 45 min) had the lowest RDS content (29.33%) and the highest SDS (51.30%) and RS (8.21%) levels. The decreased hydrolysis rate, high amylose and RS content of HMT-45 resulted in a significant decrease in estimated glycemic index (eGI) values from 51.49% (Native) to 44.16% (HMT-45) thus indicating its role in prevention of non-insulin- dependent diabetes.

4.
Invest New Drugs ; 36(2): 217-229, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29116477

RESUMEN

Deregulation of cap-dependent translation has been implicated in the malignant transformation of numerous human tissues. 4EGI-1, a novel small-molecule inhibitor of cap-dependent translation, disrupts formation of the eukaryotic initiation factor 4F (eIF4F) complex. The effects of 4EGI-1-mediated inhibition of translation initiation in malignant pleural mesothelioma (MPM) were examined. 4EGI-1 preferentially inhibited cell viability and induced apoptosis in MPM cells compared to normal mesothelial (LP9) cells. This effect was associated with hypophosphorylation of 4E-binding protein 1 (4E-BP1) and decreased protein levels of the cancer-related genes, c-myc and osteopontin. 4EGI-1 showed enhanced cytotoxicity in combination with pemetrexed or gemcitabine. Translatome-wide polysome microarray analysis revealed a large cohort of genes that were translationally regulated upon treatment with 4EGI-1. The 4EGI-1-regulated translatome was negatively correlated to a previously published translatome regulated by eIF4E overexpression in human mammary epithelial cells, which is in agreement with the notion that 4EGI-1 inhibits the eIF4F complex. These data indicate that inhibition of the eIF4F complex by 4EGI-1 or similar translation inhibitors could be a strategy for treating mesothelioma. Genome wide translational profiling identified a large cohort of promising target genes that should be further evaluated for their potential significance in the treatment of MPM.


Asunto(s)
Genoma Humano , Hidrazonas/farmacología , Neoplasias Pulmonares/metabolismo , Mesotelioma/metabolismo , Neoplasias Pleurales/metabolismo , Biosíntesis de Proteínas/efectos de los fármacos , Caperuzas de ARN/metabolismo , Tiazoles/farmacología , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Proteínas de Ciclo Celular , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Desoxicitidina/análogos & derivados , Desoxicitidina/farmacología , Desoxicitidina/uso terapéutico , Regulación hacia Abajo/efectos de los fármacos , Factor 4E Eucariótico de Iniciación/deficiencia , Factor 4E Eucariótico de Iniciación/metabolismo , Factor 4F Eucariótico de Iniciación/metabolismo , Factor 4G Eucariótico de Iniciación/metabolismo , Humanos , Neoplasias Pulmonares/patología , Mesotelioma/patología , Mesotelioma Maligno , Pemetrexed/farmacología , Pemetrexed/uso terapéutico , Fosfoproteínas/metabolismo , Fosforilación/efectos de los fármacos , Neoplasias Pleurales/patología , Polirribosomas/efectos de los fármacos , Polirribosomas/metabolismo , Unión Proteica , Proteoma/metabolismo , Reproducibilidad de los Resultados , Gemcitabina
5.
Open Res Eur ; 4: 136, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39219788

RESUMEN

This paper presents the approach adopted by the EGI-ACE project for the setup and delivery of Data Spaces for various scientific domains. The work was implemented by members of the EGI e-infrastructure and of several European Research Infrastructures in the context of the European Open Science Cloud programme. Our results are several Data Space services that enable the reuse and exploitation of open, scientific big data for compute intensive use cases. The paper illustrates the EGI-ACE approach through two examples: (1) EMSO ERIC Data Portal for seafloor and water column research and (2) ENES Data Space for climate research.


The EGI-ACE project created a number of Data Spaces for various scientific domains, allowing for easy access and reuse of open, scientific big data for compute intensive use cases. The aim of the European Commission's strategy for data is to create a common European Data Space, which will bring together relevant data infrastructures and governance frameworks to facilitate data sharing while ensuring control for individuals and companies generating the data. The Data Spaces created within EGI-ACE contribute towards achieving this goal, publishing curated data from international scientific communities 'in the cloud' and offering them for scalable exploitation and reuse through domain-specific tools and environments that offer data visualization, analysis, and mapping. The paper provides an overview of the technical and policy implementation approaches of the EGI-ACE Data Spaces and their potential future role in the single market for data in Europe. The paper presents the generic approach that EGI-ACE followed for the implementation of scientific data spaces, and illustrates this with two examples, one from climate sciences (ENES), one from marine sciences (EMSO).

6.
Bone Rep ; 16: 101179, 2022 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-35309107

RESUMEN

The apparent stiffness tensor is relevant for characterizing trabecular bone quality. Previous studies have used morphology-stiffness relationships for estimating the apparent stiffness tensor. In this paper, we propose to train spherical convolutional neural networks (SphCNNs) to estimate this tensor. Information of the edges, trabecular thickness, and spacing are summarized in functions on the unitary sphere used as inputs for the SphCNNs. The concomitant dimensionality reduction makes it possible to train neural networks on relatively small datasets. The predicted tensors were compared to the stiffness tensors computed by using the micro-finite element method (µFE), which was considered as the gold standard, and models based on fourth-order fabric tensors. Combining edges and trabecular thickness yields significant improvements in the accuracy compared to the methods based on fourth-order fabric tensors. From the results, SphCNNs are promising for replacing the more expensive µFE stiffness estimations.

7.
Foods ; 10(8)2021 Jul 21.
Artículo en Inglés | MEDLINE | ID: mdl-34441463

RESUMEN

The estimated glycemic index (eGI) value of adzuki bean powder prepared by steamed cooking (SC), extruded cooking (EC) and roller cooking (RC) was studied comparatively. Results showed that RC had the highest eGI, with 80.1, and both EC and SC resulted in a lower eGI value of 70.0 and 49.7, respectively. Compared with the EC and RC methods, the SC method provided a more intact physical barrier for starch digestion, resulting in a less destroyed cell structure. As the essential components that form the cell wall, the study further investigated the effects of protein and fiber on physicochemical properties, in vitro starch digestibility and the eGI of adzuki bean powder processed with the SC method. Viscozyme and Protamax were used to obtain the deprotein and defiber samples. Results showed that the SC treatment with Viscozyme and Protamax, respectively, had significant effects on in vitro starch digestibility. The eGI of different samples were given as follows: steamed cooking adzuki bean powder (49.7) < deproteined adzuki bean powder (60.5) < defibered adzuki bean powder (83.1), which indicates that fiber may have a greater influence on the eGI than protein.

8.
Mol Cell Biol ; 38(10)2018 05 15.
Artículo en Inglés | MEDLINE | ID: mdl-29483299

RESUMEN

The p53 tumor suppressor plays a critical role in protecting normal cells from malignant transformation. Development of small molecules to reactivate p53 in cancer cells has been an area of intense research. We previously identified an internal ribosomal entry site (IRES) within the 5' untranslated region of p53 mRNA that mediates translation of the p53 mRNA independent of cap-dependent translation. Our results also show that in response to DNA damage, cells switch from cap-dependent translation to cap-independent translation of p53 mRNA. In the present study, we discovered a specific inhibitor of cap-dependent translation, 4EGI-1, that is capable of inducing the accumulation of p53 in cancer cells retaining wild-type p53. Our results show that 4EGI-1 causes an increase in p53 IRES activity, leading to increased translation of p53 mRNA. We also observed that 4EGI-1 induces cancer cell apoptosis in a p53-dependent manner. Furthermore, 4EGI-1 induces p53 in cancer cells without causing DNA double-strand breaks. In conclusion, we discovered a mechanistic link between inhibition of cap-dependent translation and enhanced p53 accumulation. This leads to apoptosis of cancer cells without causing collateral damage to normal cells, thus providing a novel and effective therapeutic strategy for cancer.


Asunto(s)
Caperuzas de ARN/antagonistas & inhibidores , Proteína p53 Supresora de Tumor/biosíntesis , Regiones no Traducidas 5' , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Daño del ADN/genética , Células HCT116 , Humanos , Hidrazonas/farmacología , Sitios Internos de Entrada al Ribosoma/efectos de los fármacos , Biosíntesis de Proteínas/efectos de los fármacos , Biosíntesis de Proteínas/genética , Caperuzas de ARN/efectos de los fármacos , ARN Mensajero/genética , Ribosomas , Tiazoles/farmacología , Proteína p53 Supresora de Tumor/genética , Proteína p53 Supresora de Tumor/metabolismo
9.
F1000Res ; 62017.
Artículo en Inglés | MEDLINE | ID: mdl-31069047

RESUMEN

META-pipe is a complete service for the analysis of marine metagenomic data. It provides assembly of high-throughput sequence data, functional annotation of predicted genes, and taxonomic profiling. The functional annotation is computationally demanding and is therefore currently run on a high-performance computing cluster in Norway. However, additional compute resources are necessary to open the service to all ELIXIR users. We describe our approach for setting up and executing the functional analysis of META-pipe on additional academic and commercial clouds. Our goal is to provide a powerful analysis service that is easy to use and to maintain. Our design therefore uses a distributed architecture where we combine central servers with multiple distributed backends that execute the computationally intensive jobs. We believe our experiences developing and operating META-pipe provides a useful model for others that plan to provide a portal based data analysis service in ELIXIR and other organizations with geographically distributed compute and storage resources.

10.
Oncotarget ; 7(16): 21728-41, 2016 Apr 19.
Artículo en Inglés | MEDLINE | ID: mdl-26942880

RESUMEN

The eIF4F complex regulated by a various group of eIF4E-binding proteins (4E-BPs) can initial the protein synthesis. Small molecule compound 4EGI-1, an inhibitor of the cap-dependent translation initiation through disturbing the interaction between eIF4E and eIF4G which are main elements of the eIF4E complex, has been reported to suppress cell proliferation by inducing apoptosis in many types of cancer. And death receptor 5 (DR5) is a major component in the extrinsic apoptotic pathway. However, the correlation among 4EGI-1, DR5 and 4E-BPs have not been discovered in NPC now. Therefore, we intend to find out the effect of 4EGI-1 on the apoptosis process of NPC and the relationship among 4EGI-1, DR5 and 4E-BPs. Our results revealed a significant down regulation of DR5 expression in NPC tissues, which inversely correlated with lymph node metastasis status and clinical stages. Depressed DR5 expression was an independent biomarker for poor prognosis in NPC, and elevated DR5 expression showed longer overall survival time in 174 NPC patients. Besides, 4EGI-1 induced apoptosis in NPC cells through the DR5-caspase-8 axis on 4E-BP1 and eIF4E dephosphorylation exerting positive influence on their anti-tumor activities. The induction of DR5 also sensitized NPC cells to radiotherapy, and the SER was 1.195. These results establish the death receptor pathway as a novel anticancer mechanism of eIF4E/eIF4G interaction inhibitor in NPC.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/metabolismo , Apoptosis/efectos de los fármacos , Hidrazonas/farmacología , Neoplasias Nasofaríngeas/metabolismo , Fosfoproteínas/metabolismo , Receptores del Ligando Inductor de Apoptosis Relacionado con TNF/metabolismo , Tiazoles/farmacología , Adulto , Apoptosis/efectos de la radiación , Western Blotting , Proteínas de Ciclo Celular , Línea Celular Tumoral , Epitelio/metabolismo , Epitelio/patología , Epitelio/efectos de la radiación , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Neoplasias Nasofaríngeas/patología , Neoplasias Nasofaríngeas/radioterapia , Fosforilación/efectos de los fármacos , Tolerancia a Radiación/efectos de los fármacos
11.
Neurochem Int ; 90: 98-106, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26220902

RESUMEN

Translation initiation factors (eIFs) are over-activated in many human cancers and may contribute to their progression. The small molecule 4EGI-1, a potent inhibitor of translation initiation through disrupting eIF4E/eIF4G interaction, has been shown to exert anti-cancer effects in human cancer cells. The goal of the present study was to evaluate the anti-cancer effects of 4EGI-1 in human glioma U251 cells. We found that 4EGI-1 impaired the assembly of the eIF4F complex, and inhibited proliferation of U251 cells via inducing apoptosis. 4EGI-1 treatment induced collapse of mitochondrial membrane potential (MMP) and production of intracellular reactive oxygen species (ROS), which were prevented by the ROS scavenger N-acetyl-cysteine (NAC). In addition, 4EGI-1 inhibited mitochondrial ATP synthesis via suppressing complex I activity, but had no effects on mitochondrial biogenesis. The results of fluorescence staining showed that 4EGI-1 indeed fragmented the mitochondrial network of U251 cells. We found a significant decrease in optic atrophy type 1 (Opa-1) and mitofusin 1 (Mfn-1) related to fusion proteins as well as an increase in fission protein dynamin-related protein 1 (Drp-1). Furthermore, the anti-cancer effects of 4GI-1 were partially nullified by knock down of Drp-1 using siRNA. These data indicate that the use of inhibitors that directly target the translation initiation complex eIF4F could represent a potential novel approach for human glioma therapy.


Asunto(s)
Apoptosis/efectos de los fármacos , Hidrazonas/farmacología , Mitocondrias/efectos de los fármacos , Dinámicas Mitocondriales/efectos de los fármacos , Biosíntesis de Proteínas/efectos de los fármacos , Inhibidores de la Síntesis de la Proteína/farmacología , Tiazoles/farmacología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Glioma/tratamiento farmacológico , Humanos , Mitocondrias/metabolismo
12.
Food Chem ; 168: 257-61, 2015 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-25172708

RESUMEN

The purpose of this study was to determine some functional properties of taro (Colocasia esculenta L. Schott) corm, which can be a good alternative to the other dietary carbohydrate sources with its high starch content. The total phenolic and flavonoid content of taro corm was found as 205±53mgCAE/100g and 61±9mgCAE/100g, respectively. The antioxidant capacity of corm was determined as 452±72mMTEAC/100g and 244±73mMTEAC/100g, by the scavenging activity against ABTS and DPPH radicals, respectively. The free glucose content of corms was less than 1%, whereas the 60% of dry matter was composed of starch. According to the results, the taro corms' starch was highly digestible and higher than the 50% of the starch was composed of rapidly digestible starch (RDS) fractions. The estimated glycemic index (eGI) of taro corm was 63.1±2.5, indicating taro corm as a medium GI food and a good dietary carbohydrate alternative especially for diabetic people.


Asunto(s)
Antioxidantes/farmacología , Colocasia/química , Índice Glucémico , Almidón/metabolismo , Digestión , Humanos , Fenoles/análisis
13.
Cell Cycle ; 14(2): 232-42, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25607647

RESUMEN

Cap-dependent translation is a potential cancer-related target (oncotarget) due to its critical role in cancer initiation and progression. 4EGI-1, an inhibitor of eIF4E/eIF4G interaction, was discovered by screening chemical libraries of small molecules. 4EGI-1 inhibits cap-dependent translation initiation by impairing the assembly of the eIF4E/eIF4G complex, and therefore is a potential anti-cancer agent. Here, we report that 4EGI-1 also inhibits mTORC1 signaling independent of its inhibitory role on cap-dependent translation initiation. The inhibition of mTORC1 signaling by 4EGI-1 activates Akt due to both abrogation of the negative feedback loops from mTORC1 to PI3K and activation of mTORC2. We further validated that mTORC2 activity is required for 4EGI-1-mediated Akt activation. The activated Akt counteracted the anticancer effects of 4EGI-1. In support of this model, inhibition of Akt potentiates the antitumor activity of 4EGI-1 both in vitro and in a xenograft mouse model in vivo. Our results suggest that a combination of 4EGI-1and Akt inhibitor is a rational approach for the treatment of cancer.


Asunto(s)
Antineoplásicos/toxicidad , Proliferación Celular/efectos de los fármacos , Compuestos Heterocíclicos con 3 Anillos/toxicidad , Hidrazonas/toxicidad , Tiazoles/toxicidad , Proteínas Adaptadoras Transductoras de Señales/antagonistas & inhibidores , Proteínas Adaptadoras Transductoras de Señales/genética , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Animales , Antineoplásicos/uso terapéutico , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Proteínas de Ciclo Celular , Línea Celular Tumoral , Sinergismo Farmacológico , Femenino , Compuestos Heterocíclicos con 3 Anillos/uso terapéutico , Humanos , Hidrazonas/uso terapéutico , Células MCF-7 , Diana Mecanicista del Complejo 1 de la Rapamicina , Diana Mecanicista del Complejo 2 de la Rapamicina , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Complejos Multiproteicos/antagonistas & inhibidores , Complejos Multiproteicos/genética , Complejos Multiproteicos/metabolismo , Fosfatidilinositol 3-Quinasas/metabolismo , Fosfoproteínas/antagonistas & inhibidores , Fosfoproteínas/genética , Fosfoproteínas/metabolismo , Fosforilación/efectos de los fármacos , Biosíntesis de Proteínas/efectos de los fármacos , Proteínas Proto-Oncogénicas c-akt/antagonistas & inhibidores , Proteínas Proto-Oncogénicas c-akt/metabolismo , ARN Interferente Pequeño/metabolismo , Transducción de Señal/efectos de los fármacos , Serina-Treonina Quinasas TOR/antagonistas & inhibidores , Serina-Treonina Quinasas TOR/genética , Serina-Treonina Quinasas TOR/metabolismo , Tiazoles/uso terapéutico , Trasplante Heterólogo
14.
Fly (Austin) ; 8(3): 165-9, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25483009

RESUMEN

LRRK2 mutations are a frequent cause of familial Parkinson disease (PD) and are also found in a number of sporadic PD cases. PD-linked G2019S and I2020T mutations in the kinase domain of LRRK2 result in elevated kinase activity, which is required for the toxicity of these pathogenic variants in cell and animal models of PD. We recently reported that LRRK2 interacts with and phosphorylates a number of mammalian ribosomal proteins, several of which exhibit increased phosphorylation via both G2019S and I2020T LRRK2. Blocking the phosphorylation of ribosomal protein s15 through expression of phospho-deficient T136A s15 prevents age-associated locomotor deficits and dopamine neuron loss caused by G2019S LRRK2 expression in Drosophila indicating that s15 is a pathogenic LRRK2 substrate. We previously described that G2019S LRRK2 causes an induction of bulk mRNA translation that is blocked by T136A s15 or the protein synthesis inhibitor anisomycin. Here, we report the protective effects of the eIF4E/eIF4G interaction inhibitor 4EGI-1, in preventing neurodegenerative phenotypes in G2019S LRRK2 flies, and discuss how our findings and those of other groups provide a framework to begin investigating the mechanistic impact of LRRK2 on translation.


Asunto(s)
Proteínas de Drosophila/metabolismo , Drosophila/metabolismo , Hidrazonas/uso terapéutico , Enfermedad de Parkinson/enzimología , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Ribosómicas/metabolismo , Tiazoles/uso terapéutico , Animales , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Hidrazonas/farmacología , Proteína 2 Quinasa Serina-Treonina Rica en Repeticiones de Leucina , Enfermedad de Parkinson/genética , Enfermedad de Parkinson/prevención & control , Fenotipo , Biosíntesis de Proteínas/efectos de los fármacos , Tiazoles/farmacología
15.
Eur J Med Chem ; 77: 361-77, 2014 Apr 22.
Artículo en Inglés | MEDLINE | ID: mdl-24675136

RESUMEN

Protein-protein interactions are critical for regulating the activity of translation initiation factors and multitude of other cellular process, and form the largest block of untapped albeit most challenging targets for drug development. 4EGI-1, (E/Z)-2-(2-(4-(3,4-dichlorophenyl)thiazol-2-yl)hydrazono)-3-(2-nitrophenyl)propanoic acid, is a hit compound discovered in a screening campaign of small molecule libraries as an inhibitor of translation initiation factors eIF4E and eIF4G protein-protein interaction; it inhibits translation initiation in vitro and in vivo. A series of 4EGI-1-derived thiazol-2-yl hydrazones have been designed and synthesized in order to delineate the structural latitude and improve its binding affinity to eIF4E, and increase its potency in inhibiting the eIF4E/eIF4G interaction. Probing a wide range of substituents on both phenyl rings comprising the 3-phenylpropionic acid and 4-phenylthiazolidine moieties in the context of both E- and Z-isomers of 4EGI-1 led to analogs with enhanced binding affinity and translation initiation inhibitory activities.


Asunto(s)
Factor 4G Eucariótico de Iniciación/antagonistas & inhibidores , Hidrazonas/farmacología , Proteínas de Transporte Nucleocitoplasmático/antagonistas & inhibidores , Tiazoles/farmacología , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Factor 4G Eucariótico de Iniciación/química , Humanos , Hidrazonas/síntesis química , Hidrazonas/química , Estructura Molecular , Proteínas de Transporte Nucleocitoplasmático/química , Unión Proteica/efectos de los fármacos , Relación Estructura-Actividad , Tiazoles/síntesis química , Tiazoles/química
16.
Virology ; 444(1-2): 171-80, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23870416

RESUMEN

High throughput screening has rendered new inhibitors of eukaryotic protein synthesis. One such molecule, 4EGI-1 has been reported to selectively block the initiation factor eIF4E. We have investigated the action of this inhibitor on translation directed by several viral mRNAs which, in principle, do not utilize eIF4E. We found that 4EGI-1 inhibits translation directed by poliovirus IRES, in rabbit reticulocyte lysates, to a similar extent as capped mRNA. Moreover, 4EGI-1 inhibits translation driven by poliovirus IRES, both in vitro and in cultured cells, despite cleavage of eIF4G by picornavirus proteases. Finally, translation of vesicular stomatitis virus mRNAs and Sindbis virus subgenomic mRNA is blocked by 4EGI-1 in infected cells to a similar extent as cellular mRNAs. These findings cast doubt on the selective action of this inhibitor, and suggest that this molecule may affect other steps in protein synthesis unrelated to cap recognition by eIF4E.


Asunto(s)
Antivirales/farmacología , Inhibidores Enzimáticos/farmacología , Factor 4E Eucariótico de Iniciación/antagonistas & inhibidores , Factor 4E Eucariótico de Iniciación/metabolismo , Nitrocompuestos/farmacología , Biosíntesis de Proteínas/efectos de los fármacos , ARN Mensajero/metabolismo , Tiazoles/farmacología , Animales , Sistema Libre de Células , Hidrazonas , Virus ARN/genética , ARN Viral/metabolismo , Conejos
17.
Rev. cuba. estomatol ; 47(2): 157-168, abr.-jun. 2010.
Artículo en Español | LILACS, CUMED | ID: lil-584493

RESUMEN

Se realizó una investigación descriptiva transversal, con el objetivo de evaluar el nivel de conocimiento sobre implantes dentales de los estomatólogos generales básico e integrales de los municipios, Habana del Este, Centro Habana y Habana Vieja. El Ministerio de Salud Pública tiene especial interés en la implementación y generalización de las técnicas de implantología dental a nivel de los municipios por lo que esta temática se convierte en tema de necesario dominio para los estomatólogos, pues necesitan orientar, tratar y remitir a sus pacientes. Para medir los conocimientos fue aplicada una encuesta que constaba de diez preguntas, y se utilizó los criterios de conocen y desconocen, para evaluar las respuestas según su calidad. El nivel de conocimientos se clasificó en adecuado cuando la encuesta tuvo un 70 por ciento o más de respuestas con el criterio de conocen. El nivel de conocimientos fue no adecuado para los grupos de estudios y para los municipios(AU)


A cross-sectional and descriptive research was carried out to assess the knowledge level on dental implants of Basic and Integral General Stomatologists from Habana del Este, Centro Habana and Habana Vieja municipalities and due to its spreading in the different media and the interest of our Public Health Ministry in application of this technique at municipality level it becomes necessary domain of stomatologists because of they need to guide, to treat and to refer the patients. To knowledge measurement we applied a survey including ten questions using to know and not to know criteria to assess the answers according to its quality. The knowledge level was classified as suitable when there was a 70 percent or more of answers with the criterion of to know, but this knowledge level was not suitable for study groups and for the municipalities(AU)


Asunto(s)
Humanos , Implantes Dentales/efectos adversos , Implantes Dentales/tendencias , Encuestas de Salud Bucal/estadística & datos numéricos , Epidemiología Descriptiva , Estudios Transversales , Difusión de la Información/métodos
18.
J. epilepsy clin. neurophysiol ; 13(4): 191-196, Dec. 2007. graf, tab
Artículo en Inglés | LILACS | ID: lil-476668

RESUMEN

PURPOSE: This study aimed to evaluate the quality of life (QOL) and verify the domains of greater impact in patients with focal and generalized epilepsies. METHODS: The sample, composed by 57 subjects from Hospital São Paulo da Universidade Federal de São Paulo, was divided into 3 groups, temporal lobe epilepsies (TLE), extra-temporal epilepsies (Extra-TLE) and idiopathic generalized epilepsy (IGE). They answered a preliminary self-reported questionnaire to identify the perception of the most impaired aspects in their lives. The QOL was evaluated through the validated Brazilian version of the Quality of Life Epilepsy Inventory 31 (QOLIE-31). The correlation of the QOLIE-31 domains with epilepsy duration and seizure frequency was defined by dispersion graphics and also Pearson’s and Spearman’s correlation. RESULTS: The most frequently identified impact of epilepsy was related to interpersonal, familial and social relationships mentioned by 13 (22.81 percent) patients. The seizure frequency per patient in Extra-TLE group was significantly greater (p = 0.007) than in the other groups. The Cognition Functioning scores were lower for the Extra-TLE group (38.4) when compared with TLE (52.6) and IGE (62.6) (p = 0.01). The correlation between epilepsy duration and QOLIE-31 domains did not demonstrate statistical significance; however, seizure frequency was correlated with Seizures Worry (p = 0.0463, alpha = 0.05) and Medication Effects (p = 0.0476, alpha = 0.05) domains. CONCLUSIONS: 1) Interpersonal, familial, and social relationships were the dimension which most impacted daily life; 2) Cognition domain in Extra-TLE group showed the worst scores; 3) QOL scores were similar in the three groups for the majority of the QOLIE-31 domains; 4) The seizure frequency in the Extra-TLE group was significantly greater; 5) Seizure frequency was associated with worse QOLIE-31 scores in the domains Seizure Worry and Medication Effects.


OBJETIVO: Este estudo teve como objetivo avaliar a qualidade de vida (QV) em três diferentes grupos de epilepsia e verificar a esfera percebida como de maior impacto na vida diária. METODOLOGIA: A amostra foi composta por 57 pacientes com epilepsias focais e generalizadas do Hospital São Paulo, Universidade Federal de São Paulo, divididos em três grupos, epilepsias do lobo temporal (ELT), extratemporais (Extra-ELT) e generalizadas idiopáticas (EGI). Os pacientes responderam a um questionário preliminar para identificar a percepção sobre os aspectos mais comprometidos em suas vidas. A QV foi avaliada por meio da versão brasileira do Quality of Life in Epilepsy Inventory 31 (QOLIE-31). A correlação dos domínios do QOLIE-31 com a duração da epilepsia e freqüência de crises foi definida pela inspeção dos gráficos de dispersão e pela correlação de Pearson e de Spearman. Foram considerados significantes os valores de p < 0,05. RESULTADOS: Dificuldades nas relações interpessoais, familiares e sociais foram apontadas como a esfera de maior impacto relacionado à epilepsia, citada por 13 (22,81 por cento) pacientes. O QOLIE-31 mostrou resultado semelhante nos três diferentes tipos de epilepsia, com exceção do domínio Funcionamento Cognitivo. Os escores deste domínio foram significativamente menores (p = 0,01) no grupo com Extra-ELT (38,4) do que nos grupos ELT (52,6) e EGI (62,6). A duração da epilepsia não influenciou na QOL nesta amostra, porém foi observada uma correlação estatística significante entre a freqüência de crises e os domínios Efeitos da Medicação (p = 0,0476, alfa = 0,05) e Preocupação com Crises (p = 0,0463, alfa = 0,05). A freqüência de crises mostrou ainda uma diferença estatisticamente significante (p = 0.007) no grupo com Extra-ELT, que apresentou mais crises/paciente, quando comparado aos demais grupos. CONCLUSÕES: Os pacientes identificaram as relações interpessoais, familiares e sociais como sendo a área mais afetada pela...


Asunto(s)
Humanos , Calidad de Vida , Epilepsia Generalizada , Perfil de Impacto de Enfermedad , Epilepsia del Lóbulo Temporal , Encuestas y Cuestionarios , Relaciones Interpersonales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA